@misc{al-biltagi_m.a.m._beneficial_2017,
	title = {Beneficial {Effects} of {Omega}-3 {Supplement} to the {Enteral} {Feeding} in {Children} with {Mild} to {Moderate} {Sepsis}},
	abstract = {Objective: The objective was to investigate the benefits of supplementing enteral feeding with omega-3 fatty acids in children with mild to moderate sepsis and its effects on acute-phase reactants and interleukin 6 (IL-6) level. Methods: The study was a prospective randomized, double-blind, placebo-controlled study from January 2012 to June 2014, which included 2 groups of children with mild to moderate sepsis tolerating enteral feeding. Group A included 60 children supplemented with omega-3 fatty acids, whereas group B included 60 children who received enteral feeding without omega-3 supplementation. Both groups had complete blood pictures, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum albumin, and IL-6 before and after 7 days from supplementation. Results: There was a significant improvement in hemoglobin percentage (P {\textless}.0001), total white blood cell (WBC) count (P {\textless}.0001), and platelet count (P {\textless}.0001) and significant decrease in CRP (P {\textless}.0001), ESR (P {\textless}.0001), IL-6 (P {\textless}.0001), and albumin level (P {\textless}.001) in the supplemented group than the nonsupplemented group. The supplemented group also had a significantly shorter duration of stay in pediatric intensive care unit (PICU; P {\textless}.01) and decreased death rate than the nonsupplemented group. Conclusion: Children with mild to moderate sepsis showed significant improvement in inflammatory markers and had shorter PICU admission when enteral feeding was supplemented with omega-3 essential fatty acids. Copyright © The Author(s) 2015.},
	journal = {Journal of Intensive Care Medicine},
	author = {{Al-Biltagi M.A.M.} and {Abo-Elezz A.A.E.} and {Abd-Elhafez M.A.} and {Mabrouk M.M.} and {Suliman G.A.}},
	year = {2017},
	keywords = {*diet supplementation, *enteric feeding, *erythrocyte sedimentation rate, *interleukin 6, *omega 3 fatty acid/ct [Clinical Trial], *omega 3 fatty acid/dt [Drug Therapy], *sepsis, *sepsis/dt [Drug Therapy], C reactive protein, C reactive protein/ec [Endogenous Compound], Child, acute phase protein, albumin, albumin/ec [Endogenous Compound], article, clinical trial, controlled clinical trial, controlled study, disease severity, docosahexaenoic acid, double blind procedure, drug efficacy, endogenous compound, erythrocyte sedimentation rate, essential fatty acid, female, gene expression, hemoglobin, hemoglobin/ec [Endogenous Compound], human, icosapentaenoic acid, interleukin 6/ec [Endogenous Compound], length of stay, leukocyte count, major clinical study, male, mortality rate, nutritional assessment, omega 3 fatty acid, pediatric intensive care unit, placebo, preschool child, priority journal, prospective study, randomized controlled trial, sepsis/dt [Drug Therapy], serum albumin, thrombocyte count, visually impaired person}
}

{"_id":"4MbtAL2LMAwfC78s4","bibbaseid":"albiltagimam-aboelezzaae-abdelhafezma-mabroukmm-sulimanga-beneficialeffectsofomega3supplementtotheenteralfeedinginchildrenwithmildtomoderatesepsis-2017","downloads":0,"creationDate":"2017-05-12T20:20:57.854Z","title":"Beneficial Effects of Omega-3 Supplement to the Enteral Feeding in Children with Mild to Moderate Sepsis","author_short":["Al-Biltagi M.A.M.","Abo-Elezz A.A.E.","Abd-Elhafez M.A.","Mabrouk M.M.","Suliman G.A."],"year":2017,"bibtype":"misc","biburl":"http://bibbase.org/zotero/gxu917","bibdata":{"bibtype":"misc","type":"misc","title":"Beneficial Effects of Omega-3 Supplement to the Enteral Feeding in Children with Mild to Moderate Sepsis","abstract":"Objective: The objective was to investigate the benefits of supplementing enteral feeding with omega-3 fatty acids in children with mild to moderate sepsis and its effects on acute-phase reactants and interleukin 6 (IL-6) level. Methods: The study was a prospective randomized, double-blind, placebo-controlled study from January 2012 to June 2014, which included 2 groups of children with mild to moderate sepsis tolerating enteral feeding. Group A included 60 children supplemented with omega-3 fatty acids, whereas group B included 60 children who received enteral feeding without omega-3 supplementation. Both groups had complete blood pictures, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum albumin, and IL-6 before and after 7 days from supplementation. Results: There was a significant improvement in hemoglobin percentage (P \\textless.0001), total white blood cell (WBC) count (P \\textless.0001), and platelet count (P \\textless.0001) and significant decrease in CRP (P \\textless.0001), ESR (P \\textless.0001), IL-6 (P \\textless.0001), and albumin level (P \\textless.001) in the supplemented group than the nonsupplemented group. The supplemented group also had a significantly shorter duration of stay in pediatric intensive care unit (PICU; P \\textless.01) and decreased death rate than the nonsupplemented group. Conclusion: Children with mild to moderate sepsis showed significant improvement in inflammatory markers and had shorter PICU admission when enteral feeding was supplemented with omega-3 essential fatty acids. Copyright © The Author(s) 2015.","journal":"Journal of Intensive Care Medicine","author":[{"firstnames":[],"propositions":[],"lastnames":["Al-Biltagi M.A.M."],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Abo-Elezz A.A.E."],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Abd-Elhafez M.A."],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Mabrouk M.M."],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Suliman G.A."],"suffixes":[]}],"year":"2017","keywords":"*diet supplementation, *enteric feeding, *erythrocyte sedimentation rate, *interleukin 6, *omega 3 fatty acid/ct [Clinical Trial], *omega 3 fatty acid/dt [Drug Therapy], *sepsis, *sepsis/dt [Drug Therapy], C reactive protein, C reactive protein/ec [Endogenous Compound], Child, acute phase protein, albumin, albumin/ec [Endogenous Compound], article, clinical trial, controlled clinical trial, controlled study, disease severity, docosahexaenoic acid, double blind procedure, drug efficacy, endogenous compound, erythrocyte sedimentation rate, essential fatty acid, female, gene expression, hemoglobin, hemoglobin/ec [Endogenous Compound], human, icosapentaenoic acid, interleukin 6/ec [Endogenous Compound], length of stay, leukocyte count, major clinical study, male, mortality rate, nutritional assessment, omega 3 fatty acid, pediatric intensive care unit, placebo, preschool child, priority journal, prospective study, randomized controlled trial, sepsis/dt [Drug Therapy], serum albumin, thrombocyte count, visually impaired person","bibtex":"@misc{al-biltagi_m.a.m._beneficial_2017,\n\ttitle = {Beneficial {Effects} of {Omega}-3 {Supplement} to the {Enteral} {Feeding} in {Children} with {Mild} to {Moderate} {Sepsis}},\n\tabstract = {Objective: The objective was to investigate the benefits of supplementing enteral feeding with omega-3 fatty acids in children with mild to moderate sepsis and its effects on acute-phase reactants and interleukin 6 (IL-6) level. Methods: The study was a prospective randomized, double-blind, placebo-controlled study from January 2012 to June 2014, which included 2 groups of children with mild to moderate sepsis tolerating enteral feeding. Group A included 60 children supplemented with omega-3 fatty acids, whereas group B included 60 children who received enteral feeding without omega-3 supplementation. Both groups had complete blood pictures, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum albumin, and IL-6 before and after 7 days from supplementation. Results: There was a significant improvement in hemoglobin percentage (P {\\textless}.0001), total white blood cell (WBC) count (P {\\textless}.0001), and platelet count (P {\\textless}.0001) and significant decrease in CRP (P {\\textless}.0001), ESR (P {\\textless}.0001), IL-6 (P {\\textless}.0001), and albumin level (P {\\textless}.001) in the supplemented group than the nonsupplemented group. The supplemented group also had a significantly shorter duration of stay in pediatric intensive care unit (PICU; P {\\textless}.01) and decreased death rate than the nonsupplemented group. Conclusion: Children with mild to moderate sepsis showed significant improvement in inflammatory markers and had shorter PICU admission when enteral feeding was supplemented with omega-3 essential fatty acids. Copyright © The Author(s) 2015.},\n\tjournal = {Journal of Intensive Care Medicine},\n\tauthor = {{Al-Biltagi M.A.M.} and {Abo-Elezz A.A.E.} and {Abd-Elhafez M.A.} and {Mabrouk M.M.} and {Suliman G.A.}},\n\tyear = {2017},\n\tkeywords = {*diet supplementation, *enteric feeding, *erythrocyte sedimentation rate, *interleukin 6, *omega 3 fatty acid/ct [Clinical Trial], *omega 3 fatty acid/dt [Drug Therapy], *sepsis, *sepsis/dt [Drug Therapy], C reactive protein, C reactive protein/ec [Endogenous Compound], Child, acute phase protein, albumin, albumin/ec [Endogenous Compound], article, clinical trial, controlled clinical trial, controlled study, disease severity, docosahexaenoic acid, double blind procedure, drug efficacy, endogenous compound, erythrocyte sedimentation rate, essential fatty acid, female, gene expression, hemoglobin, hemoglobin/ec [Endogenous Compound], human, icosapentaenoic acid, interleukin 6/ec [Endogenous Compound], length of stay, leukocyte count, major clinical study, male, mortality rate, nutritional assessment, omega 3 fatty acid, pediatric intensive care unit, placebo, preschool child, priority journal, prospective study, randomized controlled trial, sepsis/dt [Drug Therapy], serum albumin, thrombocyte count, visually impaired person}\n}\n\n","author_short":["Al-Biltagi M.A.M.","Abo-Elezz A.A.E.","Abd-Elhafez M.A.","Mabrouk M.M.","Suliman G.A."],"key":"al-biltagi_m.a.m._beneficial_2017","id":"al-biltagi_m.a.m._beneficial_2017","bibbaseid":"albiltagimam-aboelezzaae-abdelhafezma-mabroukmm-sulimanga-beneficialeffectsofomega3supplementtotheenteralfeedinginchildrenwithmildtomoderatesepsis-2017","role":"author","urls":{},"keyword":["*diet supplementation","*enteric feeding","*erythrocyte sedimentation rate","*interleukin 6","*omega 3 fatty acid/ct [Clinical Trial]","*omega 3 fatty acid/dt [Drug Therapy]","*sepsis","*sepsis/dt [Drug Therapy]","C reactive protein","C reactive protein/ec [Endogenous Compound]","Child","acute phase protein","albumin","albumin/ec [Endogenous Compound]","article","clinical trial","controlled clinical trial","controlled study","disease severity","docosahexaenoic acid","double blind procedure","drug efficacy","endogenous compound","erythrocyte sedimentation rate","essential fatty acid","female","gene expression","hemoglobin","hemoglobin/ec [Endogenous Compound]","human","icosapentaenoic acid","interleukin 6/ec [Endogenous Compound]","length of stay","leukocyte count","major clinical study","male","mortality rate","nutritional assessment","omega 3 fatty acid","pediatric intensive care unit","placebo","preschool child","priority journal","prospective study","randomized controlled trial","sepsis/dt [Drug Therapy]","serum albumin","thrombocyte count","visually impaired person"],"downloads":0,"html":""},"search_terms":["beneficial","effects","omega","supplement","enteral","feeding","children","mild","moderate","sepsis","al-biltagi m.a.m.","abo-elezz a.a.e.","abd-elhafez m.a.","mabrouk m.m.","suliman g.a."],"keywords":["*diet supplementation","*enteric feeding","*erythrocyte sedimentation rate","*interleukin 6","*omega 3 fatty acid/ct [clinical trial]","*omega 3 fatty acid/dt [drug therapy]","*sepsis","*sepsis/dt [drug therapy]","c reactive protein","c reactive protein/ec [endogenous compound]","child","acute phase protein","albumin","albumin/ec [endogenous compound]","article","clinical trial","controlled clinical trial","controlled study","disease severity","docosahexaenoic acid","double blind procedure","drug efficacy","endogenous compound","erythrocyte sedimentation rate","essential fatty acid","female","gene expression","hemoglobin","hemoglobin/ec [endogenous compound]","human","icosapentaenoic acid","interleukin 6/ec [endogenous compound]","length of stay","leukocyte count","major clinical study","male","mortality rate","nutritional assessment","omega 3 fatty acid","pediatric intensive care unit","placebo","preschool child","priority journal","prospective study","randomized controlled trial","sepsis/dt [drug therapy]","serum albumin","thrombocyte count","visually impaired person"],"authorIDs":[],"dataSources":["9LqPNaySNpNxYBFzj"]}